Beyond CBD: Exploring the Endocannabinoid System in Health and Disease. 2018

Carl Germano

No Abstract Available.

UI MeSH Term Description Entries
D002185 Cannabidiol Compound isolated from Cannabis sativa extract. 1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-,Epidiolex
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D063388 Endocannabinoids Fatty acid derivatives that have specificity for CANNABINOID RECEPTORS. They are structurally distinct from CANNABINOIDS and were originally discovered as a group of endogenous CANNABINOID RECEPTOR AGONISTS. Endocannabinoid

Related Publications

Carl Germano
June 2019, Alternative therapies in health and medicine,
Carl Germano
April 2007, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry,
Carl Germano
January 2018, Frontiers in neuroscience,
Carl Germano
July 2016, Trends in pharmacological sciences,
Carl Germano
May 2020, International journal of molecular sciences,
Carl Germano
August 2007, Molecular neurobiology,
Carl Germano
October 2003, Current drug targets. CNS and neurological disorders,
Carl Germano
January 2008, Current pharmaceutical design,
Carl Germano
January 2008, Current pharmaceutical design,
Copied contents to your clipboard!